You are here

AstraZeneca

Eli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment

Marketwatch

Fri, 12/9/16 - 09:49 am

Alzheimer's disease

AstraZeneca cutting 700 U.S jobs, 120 in Phila. region

Bizjournals.com

Thu, 12/8/16 - 11:32 pm

AstraZeneca gives fuller picture of Tagrisso's edge in lung cancer

BioPharma Dive

Tue, 12/6/16 - 10:02 pm

non-small cell lung cancer

Star-crossed AstraZeneca strikes a drug discovery deal with upstart Bicycle

Endpoints

Thu, 12/1/16 - 10:24 am

Bicycle Therapeutics

AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro

Endpoints

Tue, 11/29/16 - 09:51 am

bispecific antibodies

Rest easy, pharma. AstraZeneca, Ranbaxy prevailed in landmark pay-for-delay case

Fierce Pharma

Wed, 11/23/16 - 10:23 am

$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market

Motley Fool

Mon, 11/21/16 - 02:35 pm

Alzheimer's disease

BACE inhibitors

Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class

Market Realist

Mon, 11/21/16 - 11:39 am

Bristol-Myers Squibb

Pfizer, AstraZeneca outpace Big Pharma in emerging markets as growth ticks upward

Fierce Pharma

Fri, 11/18/16 - 10:09 am

emerging markets

Why AstraZeneca’s Respiratory Segment Is a Key Growth Platform

Market Realist

Mon, 11/14/16 - 10:44 pm

The Performance of AstraZeneca’s Growth Platforms in 3Q16

Market Realist

Mon, 11/14/16 - 10:20 am

Inside AstraZeneca’s Revenue Fall in 3Q16

Market Realist

Sat, 11/12/16 - 09:06 am

AstraZeneca Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asthma Patients

Yahoo

Fri, 11/11/16 - 09:47 am

Astrazeneca beats 3Q profit forecasts

Yahoo/AP

Thu, 11/10/16 - 10:51 am

Here's Why AstraZeneca Dipped 14.2% in October

Motley Fool

Thu, 11/10/16 - 10:22 am

How Could a Potential Nexium Lawsuit Affect AstraZeneca?

Yahoo/GuruFocus

Fri, 11/4/16 - 09:25 am

AstraZeneca R&D leader Pangalos warns of a post-Brexit UK research retreat without reimbursement reform

Endpoints

Mon, 10/31/16 - 09:16 am

FDA slaps a partial hold on one of AstraZeneca’s crucial durvalumab programs

Endpoints

Fri, 10/28/16 - 10:12 am

clinical trials

head and neck cancer

Earnings guide: A preview of 9 big pharmas in Q3

BioPharma Dive

Wed, 10/19/16 - 11:52 am

Bristol-Myers Squibb

AstraZeneca backs ADC in $105M to support 6 clinical oncology candidates

Fierce Biotech

Tue, 10/18/16 - 11:22 am

ADC Therapeutics

Pages